- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06741761
12-hour Time Limited Feeding in Critical Care
The Safety and Feasibility of a 12-hour Time-Limited Enteral Feeding Protocol in Critically Ill Adults
This study is being done to assess the feasibility and safety of a time-restricted 12-hour enteral feeding protocol (experimental group) in comparison to a standard-of-care, 24-hour enteral feeding protocol (control group) in critically ill patients. Investigators hope to gain knowledge about how these feeding schedules affect feeding tolerance, blood sugar control, and other factors affecting critically ill adult patients.
- Investigators expect that the 12-hour feeding protocol will be tolerated similarly to the 24-hour feeding protocol and will not result in a greater number of adverse events related to feeding.
- Investigators expect that the proportion of participants in both groups receiving at least 75% of their estimated nutrition needs will be similar.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kansas
-
Kansas City, Kansas, United States, 66103
- University of Kansas Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults (≥18 years of age)
- With critical illness (hospitalized in an intensive care unit with a status of "ICU")
- Who have received orders for continuous enteral nutrition
Exclusion Criteria:
- "Comfort Measures Only" status
- Have orders to receive trickle feedings (feeding rate ≤10mL/hr)
- Recent surgical procedure on the GI tract (within previous 5 days at time of recruitment) or admission for GI bleed
- Receiving continuous sedation
- Expected to undergo a procedure requiring removal of study devices in the three days following enrollment
- History of malabsorptive bariatric surgery
- Admitted for a burn injury
- Known intolerance to feeding rates >100mL/hr
- Current diagnosis of pancreatitis, ileus or gastroparesis (only if using a gastrostomy tube)
- Requiring intermittent or continuous renal replacement therapy
- Pregnant or lactating
- On an intermittent feeding schedule
- Nutritional needs would require a rate higher than 120mL/hr on TRF12 protocol
- Lack of clearance by primary physician
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Continuous 24 hour feeding (CONT24).
24 hour tube feeding is the standard of care.
They will receive tube feeding continuously over 24 hours daily.
|
Patients in this control group will receive the standard of care which is tube feeding continuously over 24 hours.
|
|
Experimental: 12-hour time-restricted feeding (TRF12)
The 12-hour time-restricted feeding group will receive the same amount of nutrition in 12 hours as would be needed in 24 hours.
The hourly feeding rate will double.
|
The 12 hour feeding group will receive tube feeding only over a 12 hour period (6:00 AM to 6:00 PM feeding schedule).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safety and feasibility
Time Frame: From randomization up to 10 days
|
Safety will be measured by the need for pausing or discontinuing enteral feeds, gastrointestinal complications (including vomiting, abdominal distention, and diarrhea), other feeding complications (e.g., aspiration, gastric residuals), and hypoglycemic events.
Feasibility is defined as the percentage of patients who received ≥75% of their prescribed nutrition goal, and the logistical feasibility of collecting study data.
|
From randomization up to 10 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycemic control
Time Frame: From randomization up to 10 days
|
Glycemic control will be assessed using a continuous glucose monitor to measure time-in-range (%), time-above-range, and number of hypoglycemic events.
|
From randomization up to 10 days
|
|
Sleep quantity
Time Frame: From randomization up to 10 days
|
Sleep quantity scores will be measured in hours using actigraphy and the Richards-Campbell Sleep questionnaire.
|
From randomization up to 10 days
|
|
Circadian rhythm of skin surface temperature
Time Frame: From randomization up to 10 days
|
Circadian rhythm of skin surface temperature will be measured across 24-hours and the phase and amplitude of the circadian rhythm of skin temperature will be quantified
|
From randomization up to 10 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive health
Time Frame: From 1 month and 3 months post-discharge
|
National Institutes of Health Patient Reported Outcomes Measurement Information System-29 (PROMIS-29) will be used to assess depression or anxiety as a T-score two standard deviations above the mean.
A higher score in each category indicates more of the concept being measured.
|
From 1 month and 3 months post-discharge
|
|
Mental health
Time Frame: From 1 month and 3 months post-discharge
|
Mental health will be measured using the Personal Health Questionnaire-9 (PHQ-9).
To provide a numerical score, we will assess anxiety, depression, and post-traumatic stress syndrome.
The total score ranges from 0 to 27, with higher scores indicating more severe anxiety, depression and post-traumatic stress syndrome.
|
From 1 month and 3 months post-discharge
|
|
Impact of Health Status on Quality of life
Time Frame: From 1 month and 3 months post-discharge
|
Investigators will use the Health-Related Quality of Life survey to provide a measure of the impact of health status on quality of life.
|
From 1 month and 3 months post-discharge
|
Collaborators and Investigators
Investigators
- Principal Investigator: Felicia Steger, PhD, MS, RD, University of Kansas Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00161009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingDecision Making | Neonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
Assistance Publique - Hôpitaux de ParisEuropean Society of Intensive Care Medicine; French Society for Intensive Care and other collaboratorsRecruitingCritical Illness | Intensive Care Patients | Critical Illness Requiring Intensive Care - Sepsis | Critical Illness Requiring Intensive Care - Acute Brain Injury | Critical Illness Requiring Intensive Care - Major Surgery | Critical Illness Requiring Intensive Care - PolytraumaFrance
-
Boston Children's HospitalCompleted
-
Karolinska InstitutetNot yet recruitingPediatric Critical IllnessSweden
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Istanbul Medeniyet UniversityRecruiting
Clinical Trials on Continuous 24 hour feeding (CONT24).
-
University of PennsylvaniaChildren's Hospital of PhiladelphiaCompletedInfant, Premature, Diseases | Feeding Behavior | Feeding PatternsUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Arthritis Research Centre of...Recruiting
-
Sheffield Teaching Hospitals NHS Foundation TrustRecruitingColorectal Cancer | Atrial Fibrillation New OnsetUnited Kingdom
-
Central Jutland Regional HospitalCompletedArterial HypertensionDenmark
-
CMC Ambroise ParéRecruiting
-
University of North Carolina, Chapel HillCompletedObesityUnited States
-
Philipps University Marburg Medical CenterCompleted
-
University Hospital, GhentUniversity GhentRecruitingDiabetes Mellitus, Type 1Belgium
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting